Showing 4961-4970 of 21485 results for "".
- ADHD Trajectories in Children Linked to Social Contexthttps://reachmd.com/news/adhd-trajectories-children-social-context/2488144/Key Takeaways In the U.S. Adolescent Brain Cognitive Development (ABCD) cohort, child-reported family conflict, prosocial behavior, and school experiences over five years sorted into Resilient, Declining, and Low Improving trajectories. Across follow-up, 50.2% never
- Magnesium Sulfate Route Trial After Total Knee Arthroplastyhttps://reachmd.com/news/magnesium-sulfate-route-trial-after-total-knee-arthroplasty/2488130/Key Takeaways In adults undergoing primary unilateral total knee arthroplasty for knee osteoarthritis, combined intravenous plus topical magnesium sulfate did not improve the prespecified 24-hour resting VAS primary endpoint versus either route alone. The combined re
- NPAR Predicts Low Muscle Mass in Rheumatoid Arthritishttps://reachmd.com/news/npar-predicts-low-muscle-mass-in-rheumatoid-arthritis/2488128/Key Takeaways Among hospitalized adults with RA, DXA-defined low muscle mass was observed in a substantial subset. Higher NPAR was independently associated with greater odds of low muscle mass and followed a positive linear pattern. NPAR discriminated low mu
- Phase 3 Study Shows Sustained Psoriasis Responses With SSGJ-608https://reachmd.com/news/phase-3-study-shows-sustained-psoriasis-responses-with-ssgj-608/2488143/A phase 3 trial of the investigational interleukin (IL)-17A–targeting monoclonal antibody (SSGJ-608) showed high response rates through 52 weeks among adults with moderate-to-severe plaque psoriasis. Investigators for the double-blind, placebo-controlled trial included 458 adults in the sa
- Risankizumab Beats Ustekinumab for Steroid-Free Crohn’s Remissionhttps://reachmd.com/news/risankizumab-beats-ustekinumab-for-steroid-free-crohns-remission/2488134/Key Takeaways In adults with moderately to severely active Crohn’s disease, prior inadequate response or intolerance to at least 1 anti-TNF therapy, and corticosteroid use at baseline in SEQUENCE, risankizumab was associated with higher corticosteroid-free clinical, endoscopi
- Tapentadol Linked to Lower Short-Term Fall Risk Than Oxycodonehttps://reachmd.com/news/tapentadol-lower-short-term-fall-risk-oxycodone/2488122/Key Takeaways Among adults in New South Wales, Australia, who started publicly subsidized tapentadol SR or oxycodone CR products (including oxycodone CR/naloxone combinations), tapentadol initiation was associated with lower short-term risk of serious falls. Within 2
- Behçet’s Syndrome Study Links Younger Age to Lower Adherencehttps://reachmd.com/news/behcets-syndrome-younger-age-lower-adherence/2488124/Key Takeaways Among adults with Behçet’s syndrome seen in a tertiary referral clinic in Pisa, Italy, low medication adherence was reported in 21.6%. Intermediate adherence was reported in 48.8%, and high adherence was reported in 29.6%. Younger age was significant
- LEO Pharma Acquires Worldwide Rights to Dersimelagon for EPP, XLPhttps://reachmd.com/news/leo-pharma-acquires-worldwide-rights-to-dersimelagon-for-epp-xlp/2488131/LEO Pharma has entered into an agreement to acquire worldwide rights to dersimelagon from Tanabe Pharma, adding a late-stage investigational therapy for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) to its rare dermatology pipeline. Under the agreement, LEO Pharma w
- CT Body Composition Misses Cancer Nutritional Riskhttps://reachmd.com/news/ct-body-composition-misses-cancer-nutritional-risk/2488116/Key Takeaways Among hospitalized adults with cancer at a tertiary center in São Paulo, Brazil, CT identified low skeletal muscle mass in 51.1% of patients and low skeletal muscle density in 52.2%, including some with normal or elevated BMI. For CT-defined low muscle
- AI Beauty Tools May Favor Narrower Facial Aesthetic Standards: Supplementhttps://reachmd.com/news/ai-beauty-tools-may-favor-narrower-facial-aesthetic-standards-supplement/2488121/Artificial intelligence (AI) is emerging as another influence on facial aesthetic standards, potentially affecting how patients perceive attractiveness and approach cosmetic procedures, according to brief review in The Journal of Craniofacial Surgery. The authors explored how AI s